TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer.

James J Harding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.